The current and prospect for pancreatic carcinoma research

( views:, downloads: )
Journal Title:
Volume 3, Issue 02, 2003
Key Word:


  • [1]Greenlee RT, Murray T, Bolden S, et al. Cancer statistics. 2000, CA Cancer J Clin, 2000, 50:7-33.
  • [2]WANG L, YANG GH, LU XH, et al. Pancreatic cancer mortality in China,1991 ~ 2000. World J of Gastroenterol, (待发表).
  • [3]LU XH, XU T, QIAN JM, et al. Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer. Chin-Med-J(Engl), 2002, 115:1632-1636.
  • [4]Heldin CH, Miyazono K, ten Dijka P. TGF-β signaling from cell membrane to nucleus through Smad proteins. Nature, 1997, 390:465-471.
  • [5]Hahn SA, Hoque AT, Moskaluk CA, et al. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res, 1996, 56:490-494.
  • [6]Schutte M, Hruban RH, Hedrick L, et al. DPC4 gene in various tumor types. Cancer Res, 1996, 56:2527-2530.
  • [7]Kleeff J, Maruyama H, Friees H, et al. Smad6 suppresses TGF-β induced growth inhibition in colo-357 pancreatic cancer cells and is overexpressed in pancreatic cancer. Biochem Biophys Res Commun, 1999, 255:268-273.
  • [8]Kleeff J, Ishiwata T, Maruyama H, et al. The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene, 1999,18:5363-5372.
  • [9]Okami J, Yamamoto H, Fujiwara Y, et al. Overexpression of cycloxygenase-2 in carcinoma of the pancreas. Clin Cancer Res, 1999, 5:2018-2024.
  • [10]Molina MA, Sitja Arnau M, Lemoine MG, et al. Increased cycloxygenase-2 expesssion in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res, 1999, 59:4356-4362.
  • [11]Merati K, said Siadaty M, Andea A,et al. Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarci-noma and its relationship to panthologic and clinical parameters. Am J Clin Oncol, 2001, 24:447-452.
  • [12]王兴鹏,徐选福,王冰娴,等. 环氧合酶-2在胰腺癌中的表达及其与临床分期的关系. 中华消化杂志, 2001, 21:696-697.
  • [13]Husain SS, Szabo IL, Tarnawski AS. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Am J Gastroenterol, 2002, 97:542-543.
  • [14]Anderson KE, Johnson TW, Lazovich D, et al. Association between nonsteroidal anti-inflammatory drugs use and the incidence of pancreatic cancer. J Natl Cancer Inst, 2002, 94:1168-1171.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615